Slingshot members are tracking this event:

Rubius Therapeutics to File IND for RTX-134 in phenylketonuria during the first quarter of 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
RUBY Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Rtx-134, Phenylketonuria